Press Releases

Novartis Enters into Deal with Legend Biotech for $100 Million Upfront

Legend Biotech has secured an exclusive global license deal with Novartis giving the Swiss pharma access to Legend’s CAR-T cell therapies. The deal will give Novartis access to CAR-Ts that target the delta-like ligand protein (DLL3) candidate LB2102, which Legend...

Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), is collaborating with The Ohio State University Gene Therapy Institute for the development and clinical manufacturing of novel gene therapies. The collaboration was established...

Elsevier introduces authoritative scientific Datasets to fuel innovation and business-critical decisions in life sciences, chemicals and other research-intensive industries

Elsevier, a global leader in scientific information and data analytics, has announced a new offering of enriched and authoritative scientific Datasets to power data applications that solve R&D challenges. Elsevier’s Datasets enable researchers, data scientists and practice leaders to...

Vetter Development Service Rankweil successfully completes re-inspection

Vetter’s European clinical site receives permanent Manufacturer’s Authorization Successful inspection completed at clinical site Inspectors were impressed with systems and processes Austrian site supports manufacturing and quality control of Human Investigational Medicinal Products Ravensburg, Germany and Rankweil, Austria, November 9,...

Coveris to launch recycle-friendly, flexible and sustainable monomaterial solutions for medical packaging

Leading medical packaging manufacturer Coveris will launch a new recyclable thermoforming film Formpeel P at the COMPAMED show in Düsseldorf. The theme of this year’s exhibition, from 13th to 16th November, is sustainability. Formpeel P is the latest addition...

Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition

Cryoport, Inc., a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine for a new era of life sciences, announced the acquisition of Tec4med Lifescience GmbH, a...

Quotient Sciences Announces Major Investment in Sterile Fill/Finish Capacity in Response to Increasing Industry Demand

Quotient Sciences, the drug development and manufacturing accelerator, announced that it has made a major investment in the sterile fill/finish capabilities at its Alnwick, UK facility. This investment will increase the current capacity of the Annex 1 compliant facility...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read